// App-Quantinova.ai

PB2063 : Plasma from Patients under Direct Oral Anticoagulants (DOACs) Displays a Strong Resistance to Heparin Compared to Patients under Vitamin K Antagonists (VKA)

Researchers

Presenter

  • A. Vitulli

Principal Investigators

  • L. Dirienzo

  • F. Mancazzo

  • C. Dellanoce

  • O. Paoletti

  • S. Testa

  • M. Colucci

Medical Centers

  • University of Bari Aldo Moro, Department of Biomedical Sciences and Human Oncology, Bari, Italy

  • AO Istituti Ospitalieri, Cremona, Department of Clinical Pathology, Haemostasis and Thrombosis Center, Cremona, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Catalase

Drug/Treatment

  • rivaroxaban

  • Pradax

  • apixaban

  • Edoxaban

  • Evithrom

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved